FDA says all versions of Novo’s GLP-1 weight loss drugs are now availablenews2024-10-30T16:54:55+00:00October 30th, 2024|Endpoints News|
AstraZeneca China exec probed by local authoritiesnews2024-10-30T15:15:13+00:00October 30th, 2024|Endpoints News|
GSK cuts 24-valent pneumococcal program for adults due to competitionnews2024-10-30T14:39:58+00:00October 30th, 2024|Endpoints News|
Leal Therapeutics raises $45M; SynOx adds to Series Bnews2024-10-30T14:31:13+00:00October 30th, 2024|Endpoints News|
Lundbeck doubled its offer for Longboard over six months, new filing showsnews2024-10-30T14:30:56+00:00October 30th, 2024|Endpoints News|
Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapiesnews2024-10-30T12:00:15+00:00October 30th, 2024|Endpoints News|
Biogen signs molecular glue deal, raises yearly projectionsnews2024-10-30T11:26:16+00:00October 30th, 2024|Endpoints News|
Updated: Lilly’s shares tank after trimming revenue guidance. It also cut three assetsnews2024-10-30T11:16:18+00:00October 30th, 2024|Endpoints News|
Nobel winner David Baker co-founds another startup, as Archon takes an AI twist on antibodiesnews2024-10-30T11:00:26+00:00October 30th, 2024|Endpoints News|
GSK remains ‘very confident’ in RSV vaccine amid competition, sales slumpnews2024-10-30T10:59:39+00:00October 30th, 2024|Endpoints News|
